Stories tagged 'David M Hockenbery'
Machine learning provides new insights into tumor suppression
Algorithm illuminated surprising metabolic effects of important cancer gene
May 7, 2018 | by Susan Keown / Fred Hutch News Service
A machine learning algorithm helped Fred Hutch scientists solve a challenging problem in cancer genomics. And the surprising answer has revealed potential new targets for cancer drugs.
Good News at Fred Hutch
Celebrating faculty and staff achievements
March 10, 2016
Drs. Michael Emerman and Nina Salama elected to Fellowship in the American Academy of Microbiology; Dr. William Grady receives grant for esophageal cancer screening study; Dr. Andrew Hsieh earns 2016 ASCI Young Physician-Scientist Award; New interactive map is hub for global breast cancer data
Tags: Amanda Paulovich, Andrew Hsieh, Basic Sciences, Breast Cancer Initiative 2.5 (BCI2.5), Computational Biology, David M Hockenbery, esophageal adenocarcinoma, Esophageal Cancer, genomics, h pylori, Hans-Peter Kiem, hiv, Human Biology, Lawrence Corey, Michael Emerman, microbiology, Nina Salama, Oliver Press, paleovirology, Paul Nghiem, Public Health Sciences, Scott Ramsey, Stephanie Lee, William Grady
Center awarded $11.5 million for breast cancer research consortium
Porter, Cheever will lead the five-year Seattle-based SPORE in projects including development of targeted treatments for drug-resistant tumors
Nov. 15, 2010 | By Kristen Woodward
The National Cancer Institute has awarded $11.5 million to the Fred Hutchison Cancer Research Center to lead a five-year, Seattle-based breast cancer research consortium. The goal of the endeavor is to positively impact breast cancer prevention, detection, treatment and care of women who have or are at risk for the disease.
Tags: Amanda Paulovich, biomarker, Breast Cancer, cancer consortium, cancer immunotherapy, cancer research, cancer treatment, Clinical Research, David M Hockenbery, fred hutchinson cancer research center, Human Biology, James M Roberts, Kathleen E Malone, Martin Cheever, Peggy Porter, Public Health Sciences, Seattle, Stanley R Riddell
Pond poison tackles tenacious cancer cells
Modified cell toxin used to control invasive fish populations may lead to drug that lowers resistance to cancer therapies
Aug. 1, 2007 | By DEAN FORBESGaining gastrointestinal GVHD control
Phase III clinical trial on drug therapy to combat graft-vs.-host disease in stem-cell patients shows significant reduction in deaths
Jan. 29, 2007 | By DEAN FORBES
Hutchinson Center researchers have developed a new drug therapy that significantly reduces death from gastrointestinal graft-vs.-host disease in allogeneic stem-cell transplant patients. By adding a widely used topical corticosteroid to the standard GVHD treatment, researchers found it kept the potentially deadly side effect in remission and reduced death by 46 percent one year after therapy.
(RSS feeds are best viewed in browsers other than Chrome)
Editor's Picks
Acupuncture can curb treatment-related joint pain in breast cancer patients
GIVE NOW &
SAVE LIVES
Story Archive
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
Publications
Magazine Archive
Back issues of Hutch Magazine
Financial Reporting
Fiscal highlights & Annual Reports
Science Spotlight
Monthly review of Center-authored papers
Fred Hutch News
Get updates via email.
